Search

01/12/2025 Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors
Araujo-Castro, M, Torre, EM, Lozano-Aida, C, Garcia-Centeno, R, Fernandez, LG, Idrobo, C, Achote-Rea, E, Echarri, AI, Rodriguez-Argullo, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Aulinas, A, Roca, QA, Aviles, MD, Mezquita, EL, Fernandez-Argueeso, M, Molero, IG, Ruz-Caracuel, I, Aldecoa, I, Garcia, J, Martinez-Saez, E, Hanzu, F, Marazuela, M, Puig-Domingo, M, Biagetti, B. Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf252. PMID:40277238. IF:5.100(Q1/2D).
01/12/2025 Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity
Aulinas, A, Galbiati, F, Wronski, ML, Carter, CS, Nazarloo, S, Holman, K, Golden, ER, Muhammed, M, Hadaway, N, Asanza, E, Smith, SE, Plessow, F, Lawson, EA. Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With Obesity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2025; 110(12)DOI:10.1210/clinem/dgaf237. PMID:40314146. IF:5.100(Q1/2D).
01/12/2025 Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study
Biagetti, B, Cardona-Arias, A, Torre, EM, Aulinas, A, Ruz-Caracuel, I, Centeno, RG, Gonzalez, L, Echarri, AI, Rodriguez, MDM, Paja, M, Guerrero-Perez, F, Castano, JP, Garcia, MDO, Novo-Rodriguez, C, Tenorio-Jimenez, C, Villar-Taibo, R, Bernabeu, I, Diaz-Lopez, E, Calatayud, M, Alvarez-Escola, C, Rojas-Marcos, PM, Recio-Cordova, JM, Lozano-Aida, C, Roca, QA, Aviles, MD, Mezquita, EL, Argueso, MF, Molero, IG, Alberoa, I, Idrobo, C, Achote, E, Martinez-Saez, E, Marazuela, M, Puig-Domingo, M, Hanzu, F, Araujo-Castro, M. Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2025; 48(12)DOI:10.1007/s40618-025-02674-6. PMID:40779234. IF:3.500(Q2/4D).
01/11/2025 Oxytocin in hypopituitarism: What do we know?
Aulinas, A, Lawson, EA. Oxytocin in hypopituitarism: What do we know?. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:. PMID:41173566. IF:1.800(Q3/8D).
25/10/2025 Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly
Araujo-Castro, M, García-Centeno, R, González, L, Nobre, EL, Severino, MD, Goi, J, Pena, MMP, Torre, EM, Aida, CL, Novoa-Testa, I, Cordido, F, Sánchón, R, Guerrero-Pérez, F, Rodríguez, RO, Rodríguez-Jiménez, B, García, MDO, Echarri, AI, Simó-Servat, A, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Tenorio-Jimenéz, C, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, Aulinas, A, Roca, QA, Fano, MP, Martínez, AR, Cardoso, LM, Marques, P, Giustina, A, Marazuela, M, Puig-Domingo, M, Biagetti, B. Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly. Pituitary. 2025; 28(6)DOI:10.1007/s11102-025-01586-1. PMID:41139153. IF:3.400(Q2/4D).
25/10/2025 Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain
Araujo-Castro, M, García-Centeno, R, González, L, Hanzu, FA, Orois, A, Camara, R, García, MDO, Echarri, AI, Gimeno, PG, Pascual-Corrales, E, Biagetti, B, Cardona, A, Molero, IG, Simo-Servat, A, Pérez, FG, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Novo-Rodríguez, C, Jimenéz, CT, Calatayud, M, Rodríguez, MDM, Cordido, F, Castro, A, Valero, LM, Fano, MP, Goi, J, Aulinas, A, Abellán, P, Iglesias, P, Soto-Moreno, A. Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain. Journal of Clinical Medicine. 2025; 14(21)DOI:10.3390/jcm14217575. PMID:41226972. IF:2.900(Q1/2D).